KRYS · Healthcare · $9.8B
$327.18-1.62%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Float 13.6% · biweekly · settled 26.05.15
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출 $119.2M — 전 분기 $116M보다 성장했지만 속도는 눈에 띄게 느려졌어요(전분기 대비 성장률 둔화).”
In the company's words · 2026 2분기 earnings call